EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 102 filers reported holding EPIZYME INC in Q4 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $332,000 | -17.8% | 32,192 | 0.0% | 0.04% | +50.0% |
| Q2 2019 | $404,000 | -82.1% | 32,192 | -82.3% | 0.03% | -73.1% |
| Q1 2019 | $2,253,000 | +0.9% | 181,900 | -49.8% | 0.10% | -32.5% |
| Q4 2018 | $2,233,000 | +274.0% | 362,600 | +722.2% | 0.15% | +340.0% |
| Q2 2018 | $597,000 | +0.8% | 44,100 | -6.6% | 0.04% | +9.4% |
| Q4 2017 | $592,000 | +175.3% | 47,200 | +230.1% | 0.03% | +146.2% |
| Q2 2017 | $215,000 | -54.4% | 14,300 | -70.2% | 0.01% | -65.8% |
| Q3 2016 | $472,000 | -86.1% | 48,000 | -85.5% | 0.04% | -88.0% |
| Q2 2016 | $3,392,000 | -15.5% | 331,300 | 0.0% | 0.32% | -21.9% |
| Q1 2016 | $4,015,000 | +15.5% | 331,300 | +52.6% | 0.41% | -8.4% |
| Q4 2015 | $3,477,000 | +15.9% | 217,100 | -7.1% | 0.44% | +13.6% |
| Q3 2015 | $3,001,000 | – | 233,600 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |